Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-04-06 00:00:00 ET · period of report 2023-04-04 · accession 0001209191-23-023588 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-06 | 2023-04-04 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $315.81 | -522 | 47.3K | -1% | -$164.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-04 | S | D | 94 | $315.66 | 47,497 | D | — | — | (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $315.66 (range $315.08 to $315.96). |
| 2 | Common | Common Stock | 2023-04-04 | S | D | 211 | $314.22 | 47,591 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $314.22 (range $313.72 to $314.70). (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-04-04 | S | D | 31 | $318.68 | 47,280 | D | — | — | |
| 4 | Common | Common Stock | 2023-04-04 | S | D | 90 | $316.76 | 47,407 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $316.76 (range $316.41 to $317.20). (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-04-04 | S | D | 96 | $317.65 | 47,311 | D | — | — | (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $317.65 (range $317.49 to $317.74). |